Publication: Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers Media S.A.
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Koudriavtseva, Tatiana, and Caterina Mainero. 2016. “Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation.” Frontiers in Human Neuroscience 10 (1): 226. doi:10.3389/fnhum.2016.00226. http://dx.doi.org/10.3389/fnhum.2016.00226.
Research Data
Abstract
Description
Other Available Sources
Keywords
Opinion, multiple sclerosis, brain atrophy, inflammation, neuroprotection, disease modifying therapy
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service